Mohamed Reham, Iqbal Asif, Elawadi Abosaleh Abosaleh
National Cancer Institute, Radiotherapy and Nuclear Medicine Department, Cairo University, Cairo, Egypt.
Radiation Oncology Department, King Fahad Medical City, Riyadh, Saudi Arabia.
J Egypt Natl Canc Inst. 2022 Nov 21;34(1):48. doi: 10.1186/s43046-022-00149-w.
Surgical resection is the primary treatment for advanced-stage heterotopic ossification (HO), with a high incidence of local recurrence reaching up to 50%. Postoperative radiotherapy (PORT) and indomethacin are commonly used prophylactic strategies following surgery. The study aims to assess the safety and effectiveness of PORT in advanced-stage HO patients having motor vehicle accidents (MVA).
Medical records of patients having HO following MVA between 2006 and 2021 were retrospectively reviewed. Thirty-nine patients with advanced disease (35 had hip HO and 4 had elbow HO) were included in the study.
Excision of HO with joint preservation was performed for 82% of patients, while 18% had a joint replacement. Seven to 8 Gy radiation was given to all patients within 3 days postoperatively. A ninty seven percent of patients regained partially the movement range. The mean follow-up time was 74 months. Six patients had treatment failure, with only one having a recurrence of HO. The 8-year treatment failure-free rate (8-y TFFR) was 79.3±9%, and the 5-year HO failure-free rate (5y-HOFFR) was 97.2±3%. Acute side effects were experienced in 13% of patients but resolved without any consequences. Despite the relatively long follow-up time, we did not report any absolute infertility or secondary malignancies related to the radiation. The testicular mean calculated dose was 33±44 cGy, and the mean measured dose was 58±40 cGy. Of the 35 patients who received radiation to the pelvis, 26 were married, and all did not experience infertility post-treatment.
PORT proved an effective and safe treatment for advanced-stage HO disease. The treatment failure is mainly related to surgical difficulties due to advanced disease. Treatment using a 3-dimensional or intensity-modulated radiation therapy is not associated with serious side effects like second malignancy or absolute infertility.
手术切除是晚期异位骨化(HO)的主要治疗方法,局部复发率高达50%。术后放疗(PORT)和吲哚美辛是术后常用的预防策略。本研究旨在评估PORT对晚期HO且发生机动车事故(MVA)患者的安全性和有效性。
回顾性分析2006年至2021年间发生MVA后患有HO的患者的病历。39例晚期疾病患者(35例为髋部HO,4例为肘部HO)纳入研究。
82%的患者进行了保留关节的HO切除术,18%的患者进行了关节置换。所有患者术后3天内接受7至8 Gy的放疗。97%的患者部分恢复了活动范围。平均随访时间为74个月。6例患者治疗失败,仅1例HO复发。8年无治疗失败率(8-y TFFR)为79.3±9%,5年HO无失败率(5y-HOFFR)为97.2±3%。13%的患者出现急性副作用,但均无不良后果地得到缓解。尽管随访时间相对较长,但我们未报告任何与放疗相关的绝对不孕或继发性恶性肿瘤。睾丸平均计算剂量为33±44 cGy,平均测量剂量为58±40 cGy。在35例接受盆腔放疗的患者中,26例已婚,所有患者治疗后均未出现不孕。
PORT被证明是治疗晚期HO疾病的有效且安全的方法。治疗失败主要与晚期疾病导致的手术困难有关。使用三维或调强放射治疗不会产生如继发性恶性肿瘤或绝对不孕等严重副作用。